Saba Assar, MD
Cardiovascular Disease · New York, NYNPI 1730575275
Payments from drug & device makers
Across 168 payments — averaging $282.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$29K
- Medtronic$10K
- Abbott$4K
- Abiomed$1K
- Shockwave Medical, Inc$640
- AstraZeneca$345
- plus $3K from 21 others
What the payments were for
- Grants$33,00070%
- Travel & lodging$5,27511%
- Food & beverage$8,85019%
- Education$3451%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 47 | $28,905 |
| Medtronic | 20 | $9,795 |
| Abbott | 28 | $3,877 |
| Abiomed | 14 | $1,215 |
| Shockwave Medical, Inc | 4 | $640 |
| AstraZeneca | 6 | $345 |
| Cardiovascular Systems Inc. | 4 | $332 |
| Stryker | 4 | $269 |
| Cardiva Medical, Inc. | 3 | $226 |
| Verge Medical, Inc. | 2 | $216 |
| Amgen | 6 | $211 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $203 |
| Chiesi USA, Inc. | 4 | $183 |
| Heartflow, Inc. | 1 | $182 |
| Teleflex LLC | 1 | $140 |
| Penumbra, Inc. | 1 | $139 |
| Edwards Lifesciences | 1 | $118 |
| Terumo Medical Corporation | 1 | $114 |
| Asahi Intecc USA, Inc. | 6 | $77 |
| Boehringer Ingelheim | 4 | $61 |
| Philips North America LLC | 1 | $45 |
| E.r. Squibb & Sons, L.L.C. | 2 | $43 |
| Acist Medical Systems, Inc. | 1 | $40 |
| Biotronik Inc. | 1 | $35 |
| Johnson & Johnson | 1 | $20 |
| Ironshore Pharmaceuticals Inc. | 1 | $20 |
| Novartis | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RESOLUTE ONYX$8,140
- DRAGONFLY OPSTAR$1,714
- OPTIS$1,472
- GENERAL - THERAPIES$1,156
- Impella$730
- ONYX FRONTIER$673
- AVVIGO Guidance System$654
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$543
- Diamondback Coronary$291
- Resolute$280
- FLASH Ostial System$216
- Cardiva VASCADE 5F VCS$200
- FFRct$182
- GENERAL VASCULAR ACCESS$171
- ROTAPRO$169
- COROFLOW$158
- FFRangio$146
- TURNPIKE$140
- Indigo System$139
- KENGREAL$132
How this compares
$47,470 in reported general payments places this provider in the 90th percentile of 2,302 cardiovascular disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $10,586 |
| Metoprolol Succinate | 18 | $376 |
| Atorvastatin Calcium | 37 | $364 |
| ClopidogrelClopidogrel Bisulfate | 26 | $253 |
| Amlodipine Besylate | 22 | $192 |
| Losartan Potassium | 18 | $149 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 17 | $117 |
| Carvedilol | 12 | $103 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in New York
- James MinNew York$41.1M
- Robert RosensonNew York$6.9M
- Roxana MehranNew York$6.4M
- Roger HajjarNew York$5.2M
- Philippe GenereuxNew York$4.4M
- Gregg StoneNew York$3.7M
- Valentin FusterNew York$2.9M
- Tamim NazifNew York$2.2M
- Howard WeintraubNew York$1.7M
- Anuradha Lala-TrindadeNew York$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.